In serum-free medium, rosiglitazone, a peroxisome proliferator activator receptor-γ agonist, was reported to induce immortalised human meibomian gland epithelia cell differentiation, neutral lipid accumulation and expression of key biomarkers of differentiation.
[Ocular Surface]